ID   RGCC_RAT                Reviewed;         137 AA.
AC   Q9Z2P4;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   24-JUL-2024, entry version 106.
DE   RecName: Full=Regulator of cell cycle RGCC;
DE   AltName: Full=Response gene to complement 32 protein;
DE            Short=RGC-32;
GN   Name=Rgcc; Synonyms=Rgc32;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INDUCTION, SUBCELLULAR LOCATION,
RP   INTERACTION WITH CDK1, AND TISSUE SPECIFICITY.
RX   PubMed=9756947; DOI=10.1074/jbc.273.41.26977;
RA   Badea T.C., Niculescu F.I., Soane L., Shin M.L., Rus H.;
RT   "Molecular cloning and characterization of RGC-32, a novel gene induced by
RT   complement activation in oligodendrocytes.";
RL   J. Biol. Chem. 273:26977-26981(1998).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-91 AND SER-97, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Modulates the activity of cell cycle-specific kinases.
CC       Enhances CDK1 activity. May contribute to the regulation of the cell
CC       cycle. Fibrogenic factor contributing to the pathogenesis of renal
CC       fibrosis through fibroblast activation (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:9756947}.
CC   -!- SUBUNIT: Interacts with PLK1 (By similarity). Interacts with CDK1.
CC       Interacts with SMAD3 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9756947}. Nucleus
CC       {ECO:0000250}. Cytoplasm, cytoskeleton, microtubule organizing center,
CC       centrosome {ECO:0000250}. Note=Cytoplasmic in unstimulated cells.
CC       Nuclear after activation by complement. Associated with the centrosome
CC       during prometaphase and metaphase (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Detected in kidney, heart, brain, lung, skin,
CC       spleen and thymus. {ECO:0000269|PubMed:9756947}.
CC   -!- INDUCTION: Up-regulated in oligodendrocytes in response to complement
CC       activation. {ECO:0000269|PubMed:9756947}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF036548; AAC68839.1; -; mRNA.
DR   RefSeq; NP_446460.1; NM_054008.1.
DR   AlphaFoldDB; Q9Z2P4; -.
DR   STRING; 10116.ENSRNOP00000060481; -.
DR   iPTMnet; Q9Z2P4; -.
DR   PhosphoSitePlus; Q9Z2P4; -.
DR   PaxDb; 10116-ENSRNOP00000060481; -.
DR   Ensembl; ENSRNOT00000068216.3; ENSRNOP00000060481.2; ENSRNOG00000042960.3.
DR   GeneID; 117183; -.
DR   KEGG; rno:117183; -.
DR   UCSC; RGD:619721; rat.
DR   AGR; RGD:619721; -.
DR   CTD; 28984; -.
DR   RGD; 619721; Rgcc.
DR   eggNOG; ENOG502S1UB; Eukaryota.
DR   GeneTree; ENSGT00390000011709; -.
DR   HOGENOM; CLU_154700_0_0_1; -.
DR   InParanoid; Q9Z2P4; -.
DR   OrthoDB; 5359650at2759; -.
DR   PhylomeDB; Q9Z2P4; -.
DR   PRO; PR:Q9Z2P4; -.
DR   Proteomes; UP000002494; Chromosome 15.
DR   Bgee; ENSRNOG00000042960; Expressed in thymus and 18 other cell types or tissues.
DR   GO; GO:0005813; C:centrosome; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0030295; F:protein kinase activator activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:BHF-UCL.
DR   GO; GO:0070412; F:R-SMAD binding; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; ISO:RGD.
DR   GO; GO:0006956; P:complement activation; ISO:RGD.
DR   GO; GO:0072537; P:fibroblast activation; ISS:UniProtKB.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0043537; P:negative regulation of blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:2000048; P:negative regulation of cell-cell adhesion mediated by cadherin; ISO:RGD.
DR   GO; GO:0001818; P:negative regulation of cytokine production; ISO:RGD.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; ISO:RGD.
DR   GO; GO:0001100; P:negative regulation of exit from mitosis; ISO:RGD.
DR   GO; GO:0090272; P:negative regulation of fibroblast growth factor production; ISO:RGD.
DR   GO; GO:1901991; P:negative regulation of mitotic cell cycle phase transition; ISO:RGD.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; ISO:RGD.
DR   GO; GO:0001819; P:positive regulation of cytokine production; ISO:RGD.
DR   GO; GO:2000573; P:positive regulation of DNA biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:2000353; P:positive regulation of endothelial cell apoptotic process; ISO:RGD.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:1901203; P:positive regulation of extracellular matrix assembly; ISO:RGD.
DR   GO; GO:0003331; P:positive regulation of extracellular matrix constituent secretion; ISO:RGD.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0045840; P:positive regulation of mitotic nuclear division; ISO:RGD.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; NAS:BHF-UCL.
DR   InterPro; IPR029252; RGCC.
DR   PANTHER; PTHR32193; REGULATOR OF CELL CYCLE RGCC; 1.
DR   PANTHER; PTHR32193:SF3; REGULATOR OF CELL CYCLE RGCC; 1.
DR   Pfam; PF15151; RGCC; 1.
PE   1: Evidence at protein level;
KW   Cell cycle; Cytoplasm; Cytoskeleton; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..137
FT                   /note="Regulator of cell cycle RGCC"
FT                   /id="PRO_0000274703"
FT   REGION          57..111
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        66..108
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBX1"
FT   MOD_RES         69
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H4X1"
FT   MOD_RES         71
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H4X1"
FT   MOD_RES         75
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H4X1"
FT   MOD_RES         91
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         97
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         111
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H4X1"
SQ   SEQUENCE   137 AA;  14766 MW;  0CBE742C5FDC544C CRC64;
     MKPPSTQSSP AAVAAAAPAM DSAAAADLTD VLCEFDAVLA DFASPFHERH FHYEEHLERM
     KRRSSASVSD SSGFSDSESA DSLYRDSFTF SDEKLNSPTD STPALLSSAV TPRKAKLGDT
     KELEDFIADL DRTLASM
//
